White House officials on Tuesday shot down a report speculating President Trump gained access to the retatrutide weight loss drug under the Food and Drug Administration’s (FDA) “compassionate use ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The White House has denied that President Donald Trump was given an ...

Caitlin Clark puts WNBA on notice after making history in Fever win FDA identifies potential culprit in cyclosporiasis outbreak as illness spreads nationwide Rising prices push six major burger chains ...